Share Price and Basic Stock Data
Last Updated: March 8, 2025, 10:43 am
PEG Ratio | 3.04 |
---|
Competitors of Symphony Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Misquita Engineering Ltd | 46.5 Cr. | 126 | 177/62.0 | 89.5 | 30.4 | 0.00 % | 1.57 % | 3.43 % | 10.0 |
IKIO Lighting Ltd | 1,624 Cr. | 210 | 343/165 | 38.1 | 71.2 | 0.48 % | 21.7 % | 17.5 % | 10.0 |
Elin Electronics Ltd | 587 Cr. | 118 | 282/108 | 37.5 | 104 | 0.00 % | 5.08 % | 2.75 % | 5.00 |
CWD Ltd | 336 Cr. | 931 | 1,144/590 | 184 | 91.4 | 0.00 % | 7.92 % | 4.56 % | 10.0 |
Calcom Vision Ltd | 125 Cr. | 89.2 | 179/77.0 | 42.4 | 54.7 | 0.00 % | 6.38 % | 1.81 % | 10.0 |
Industry Average | 18,126.43 Cr | 1,303.96 | 56.49 | 106.91 | 0.25% | 16.63% | 14.78% | 6.50 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 205 | 384 | 329 | 274 | 277 | 308 | 302 | 275 | 247 | 332 | 531 | 315 | 242 |
Expenses | 175 | 302 | 295 | 237 | 233 | 285 | 276 | 234 | 203 | 275 | 420 | 251 | 213 |
Operating Profit | 30 | 82 | 34 | 37 | 44 | 23 | 26 | 41 | 44 | 57 | 111 | 64 | 29 |
OPM % | 15% | 21% | 10% | 14% | 16% | 7% | 9% | 15% | 18% | 17% | 21% | 20% | 12% |
Other Income | 7 | 16 | 12 | 14 | 14 | 10 | 14 | 11 | 15 | 9 | 9 | 20 | -39 |
Interest | 3 | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 3 | 2 | 3 | 2 | 2 |
Depreciation | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 5 | 6 | 6 |
Profit before tax | 28 | 90 | 38 | 43 | 48 | 23 | 30 | 43 | 50 | 58 | 112 | 76 | -18 |
Tax % | 25% | 29% | 24% | 26% | 19% | 30% | 20% | 19% | 18% | 17% | 21% | 26% | -44% |
Net Profit | 21 | 64 | 29 | 32 | 39 | 16 | 24 | 35 | 41 | 48 | 88 | 56 | -10 |
EPS in Rs | 3.00 | 9.01 | 4.15 | 4.72 | 5.57 | 2.29 | 3.48 | 5.08 | 5.95 | 6.96 | 12.76 | 8.12 | -1.45 |
Last Updated: February 28, 2025, 4:48 pm
Below is a detailed analysis of the quarterly data for Symphony Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹242.00 Cr.. The value appears to be declining and may need further review. It has decreased from 315.00 Cr. (Sep 2024) to ₹242.00 Cr., marking a decrease of 73.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹213.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 251.00 Cr. (Sep 2024) to ₹213.00 Cr., marking a decrease of 38.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 64.00 Cr. (Sep 2024) to ₹29.00 Cr., marking a decrease of 35.00 Cr..
- For OPM %, as of Dec 2024, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Sep 2024) to 12.00%, marking a decrease of 8.00%.
- For Other Income, as of Dec 2024, the value is ₹-39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Sep 2024) to ₹-39.00 Cr., marking a decrease of 59.00 Cr..
- For Interest, as of Dec 2024, the value is ₹2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 2.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹6.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 6.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹-18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 76.00 Cr. (Sep 2024) to ₹-18.00 Cr., marking a decrease of 94.00 Cr..
- For Tax %, as of Dec 2024, the value is -44.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Sep 2024) to -44.00%, marking a decrease of 70.00%.
- For Net Profit, as of Dec 2024, the value is ₹-10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Sep 2024) to ₹-10.00 Cr., marking a decrease of 66.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is -1.45. The value appears to be declining and may need further review. It has decreased from ₹8.12 (Sep 2024) to -1.45, marking a decrease of ₹9.57.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 2:41 pm
Metric | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 347 | 487 | 525 | 446 | 764 | 798 | 844 | 1,103 | 900 | 1,039 | 1,188 | 1,156 | 1,420 |
Expenses | 269 | 364 | 393 | 309 | 565 | 579 | 711 | 889 | 759 | 877 | 1,048 | 985 | 1,159 |
Operating Profit | 78 | 123 | 132 | 136 | 199 | 220 | 133 | 213 | 140 | 162 | 140 | 171 | 261 |
OPM % | 22% | 25% | 25% | 31% | 26% | 28% | 16% | 19% | 16% | 16% | 12% | 15% | 18% |
Other Income | 18 | 16 | 34 | 33 | 43 | 54 | 15 | 51 | 24 | 40 | 50 | 48 | -1 |
Interest | 1 | 0 | 1 | 0 | 1 | 2 | 8 | 13 | 12 | 10 | 12 | 12 | 9 |
Depreciation | 4 | 4 | 4 | 4 | 7 | 7 | 10 | 21 | 21 | 24 | 26 | 26 | 23 |
Profit before tax | 91 | 135 | 161 | 165 | 235 | 265 | 130 | 230 | 131 | 168 | 152 | 181 | 228 |
Tax % | 34% | 22% | 28% | 28% | 29% | 27% | 30% | 21% | 18% | 28% | 24% | 18% | |
Net Profit | 60 | 106 | 116 | 118 | 166 | 193 | 92 | 182 | 107 | 121 | 116 | 148 | 182 |
EPS in Rs | 8.59 | 15.10 | 16.56 | 16.91 | 23.77 | 27.52 | 13.19 | 25.94 | 15.34 | 17.20 | 16.64 | 21.48 | 26.39 |
Dividend Payout % | 38% | 43% | 42% | 74% | 19% | 16% | 34% | 89% | 33% | 52% | 30% | 61% |
YoY Net Profit Growth
Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 40.68% | 16.27% | -52.33% | 97.83% | -41.21% | 13.08% | -4.13% | 27.59% |
Change in YoY Net Profit Growth (%) | 0.00% | -24.41% | -68.60% | 150.16% | -139.03% | 54.29% | -17.22% | 31.72% |
Symphony Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2016-2017 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 13% |
5 Years: | 7% |
3 Years: | 9% |
TTM: | 25% |
Compounded Profit Growth | |
---|---|
10 Years: | 10% |
5 Years: | 6% |
3 Years: | 9% |
TTM: | 94% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | -1% |
3 Years: | 3% |
1 Year: | 30% |
Return on Equity | |
---|---|
10 Years: | 23% |
5 Years: | 18% |
3 Years: | 15% |
Last Year: | 18% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 7:32 pm
Month | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7 | 7 | 7 | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Reserves | 215 | 269 | 299 | 312 | 451 | 598 | 652 | 625 | 745 | 825 | 867 | 735 | 716 |
Borrowings | 0 | 0 | 0 | 0 | 19 | 26 | 188 | 210 | 219 | 254 | 232 | 170 | 172 |
Other Liabilities | 94 | 118 | 116 | 104 | 121 | 119 | 211 | 215 | 236 | 267 | 281 | 291 | 561 |
Total Liabilities | 316 | 393 | 423 | 422 | 605 | 757 | 1,065 | 1,064 | 1,214 | 1,361 | 1,394 | 1,210 | 1,463 |
Fixed Assets | 70 | 70 | 68 | 77 | 79 | 82 | 237 | 318 | 354 | 355 | 351 | 327 | 339 |
CWIP | 4 | 8 | 0 | 3 | 0 | 0 | 6 | 2 | 0 | 0 | 0 | 0 | 0 |
Investments | 99 | 199 | 242 | 162 | 292 | 422 | 458 | 412 | 484 | 500 | 527 | 373 | 677 |
Other Assets | 144 | 117 | 112 | 180 | 234 | 252 | 363 | 332 | 375 | 506 | 516 | 510 | 447 |
Total Assets | 316 | 393 | 423 | 422 | 605 | 757 | 1,065 | 1,064 | 1,214 | 1,361 | 1,394 | 1,210 | 1,463 |
Below is a detailed analysis of the balance sheet data for Symphony Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹14.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹716.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹735.00 Cr. (Mar 2024) to ₹716.00 Cr., marking a decrease of 19.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹172.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹170.00 Cr. (Mar 2024) to ₹172.00 Cr., marking an increase of 2.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹561.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹291.00 Cr. (Mar 2024) to ₹561.00 Cr., marking an increase of 270.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹1,463.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,210.00 Cr. (Mar 2024) to ₹1,463.00 Cr., marking an increase of 253.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹339.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹327.00 Cr. (Mar 2024) to ₹339.00 Cr., marking an increase of 12.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
- For Investments, as of Sep 2024, the value is ₹677.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹373.00 Cr. (Mar 2024) to ₹677.00 Cr., marking an increase of 304.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹447.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹510.00 Cr. (Mar 2024) to ₹447.00 Cr., marking a decrease of 63.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹1,463.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,210.00 Cr. (Mar 2024) to ₹1,463.00 Cr., marking an increase of 253.00 Cr..
Notably, the Reserves (₹716.00 Cr.) exceed the Borrowings (172.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 78.00 | 123.00 | 132.00 | 136.00 | 180.00 | 194.00 | -55.00 | 3.00 | -79.00 | -92.00 | -92.00 | 1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
No data available for the Financial Efficiency data table.
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
UTI Value Fund | 734,784 | 0.82 | 69.12 | 692 | 2025-03-08 | 106082.66% |
Axis ELSS Tax Saver Fund | 728,333 | 0.2 | 68.51 | 692 | 2025-03-08 | 105150.43% |
Franklin India Smaller Companies Fund | 292,158 | 0.23 | 27.48 | 692 | 2025-03-08 | 42119.36% |
Axis ESG Integration Strategy Fund | 83,302 | 0.58 | 7.84 | 692 | 2025-03-08 | 11937.86% |
UTI Conservative Hybrid Fund | 40,000 | 0.24 | 3.76 | 692 | 2025-03-08 | 5680.35% |
Nippon India Nifty Smallcap 250 Index Fund | 11,440 | 0.1 | 1.08 | 692 | 2025-03-08 | 1553.18% |
Motilal Oswal Nifty Smallcap 250 Index Fund | 6,993 | 0.1 | 0.66 | 692 | 2025-03-08 | 910.55% |
SBI Nifty Smallcap 250 Index Fund | 5,810 | 0.1 | 0.55 | 692 | 2025-03-08 | 739.6% |
Motilal Oswal Nifty 500 Index Fund | 692 | 0.01 | 0.07 | 692 | 2025-03-08 | 0% |
Edelweiss Nifty Smallcap 250 Index Fund | 315 | 0.1 | 0.03 | 692 | 2025-03-08 | -54.48% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Basic EPS (Rs.) | 21.43 | 16.64 | 17.20 | 15.35 | 25.98 |
Diluted EPS (Rs.) | 21.43 | 16.64 | 17.20 | 15.35 | 25.98 |
Cash EPS (Rs.) | 25.23 | 20.35 | 20.73 | 18.41 | 29.01 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 108.63 | 125.93 | 120.77 | 109.21 | 91.99 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 108.63 | 125.93 | 120.77 | 109.21 | 91.99 |
Revenue From Operations / Share (Rs.) | 167.67 | 169.77 | 148.55 | 128.64 | 157.63 |
PBDIT / Share (Rs.) | 31.86 | 26.96 | 28.68 | 24.36 | 38.07 |
PBIT / Share (Rs.) | 28.11 | 23.18 | 25.22 | 21.30 | 35.05 |
PBT / Share (Rs.) | 26.24 | 21.72 | 23.95 | 18.75 | 32.95 |
Net Profit / Share (Rs.) | 21.48 | 16.57 | 17.28 | 15.35 | 25.99 |
NP After MI And SOA / Share (Rs.) | 21.48 | 16.64 | 17.20 | 15.35 | 25.94 |
PBDIT Margin (%) | 19.00 | 15.88 | 19.30 | 18.94 | 24.15 |
PBIT Margin (%) | 16.76 | 13.65 | 16.98 | 16.55 | 22.23 |
PBT Margin (%) | 15.65 | 12.79 | 16.12 | 14.57 | 20.90 |
Net Profit Margin (%) | 12.81 | 9.75 | 11.63 | 11.93 | 16.48 |
NP After MI And SOA Margin (%) | 12.81 | 9.80 | 11.57 | 11.92 | 16.45 |
Return on Networth / Equity (%) | 19.77 | 13.21 | 14.33 | 14.13 | 28.38 |
Return on Capital Employeed (%) | 23.24 | 16.15 | 17.57 | 15.75 | 32.29 |
Return On Assets (%) | 12.16 | 8.29 | 8.80 | 8.80 | 17.04 |
Long Term Debt / Equity (X) | 0.07 | 0.09 | 0.13 | 0.18 | 0.11 |
Total Debt / Equity (X) | 0.19 | 0.22 | 0.26 | 0.24 | 0.27 |
Asset Turnover Ratio (%) | 0.88 | 0.71 | 0.57 | 0.50 | 0.78 |
Current Ratio (X) | 1.61 | 1.80 | 2.30 | 2.53 | 2.05 |
Quick Ratio (X) | 1.01 | 1.18 | 1.82 | 2.10 | 1.67 |
Inventory Turnover Ratio (X) | 0.56 | 0.00 | 0.00 | 0.04 | 0.38 |
Dividend Payout Ratio (NP) (%) | 27.92 | 60.09 | 0.00 | 0.00 | 94.45 |
Dividend Payout Ratio (CP) (%) | 23.78 | 48.96 | 0.00 | 0.00 | 84.59 |
Earning Retention Ratio (%) | 72.08 | 39.91 | 0.00 | 0.00 | 5.55 |
Cash Earning Retention Ratio (%) | 76.22 | 51.04 | 0.00 | 0.00 | 15.41 |
Interest Coverage Ratio (X) | 21.08 | 18.44 | 22.49 | 15.91 | 24.93 |
Interest Coverage Ratio (Post Tax) (X) | 15.45 | 12.33 | 14.55 | 11.69 | 18.39 |
Enterprise Value (Cr.) | 5953.91 | 7242.13 | 7834.17 | 8991.19 | 5685.75 |
EV / Net Operating Revenue (X) | 5.15 | 6.10 | 7.54 | 9.99 | 5.16 |
EV / EBITDA (X) | 27.11 | 38.40 | 39.05 | 52.76 | 21.35 |
MarketCap / Net Operating Revenue (X) | 5.06 | 5.98 | 7.39 | 9.82 | 5.02 |
Retention Ratios (%) | 72.07 | 39.90 | 0.00 | 0.00 | 5.54 |
Price / BV (X) | 7.81 | 8.06 | 9.14 | 11.64 | 8.66 |
Price / Net Operating Revenue (X) | 5.06 | 5.98 | 7.39 | 9.82 | 5.02 |
EarningsYield | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 |
After reviewing the key financial ratios for Symphony Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 21.43. This value is within the healthy range. It has increased from 16.64 (Mar 23) to 21.43, marking an increase of 4.79.
- For Diluted EPS (Rs.), as of Mar 24, the value is 21.43. This value is within the healthy range. It has increased from 16.64 (Mar 23) to 21.43, marking an increase of 4.79.
- For Cash EPS (Rs.), as of Mar 24, the value is 25.23. This value is within the healthy range. It has increased from 20.35 (Mar 23) to 25.23, marking an increase of 4.88.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 108.63. It has decreased from 125.93 (Mar 23) to 108.63, marking a decrease of 17.30.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 108.63. It has decreased from 125.93 (Mar 23) to 108.63, marking a decrease of 17.30.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 167.67. It has decreased from 169.77 (Mar 23) to 167.67, marking a decrease of 2.10.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 31.86. This value is within the healthy range. It has increased from 26.96 (Mar 23) to 31.86, marking an increase of 4.90.
- For PBIT / Share (Rs.), as of Mar 24, the value is 28.11. This value is within the healthy range. It has increased from 23.18 (Mar 23) to 28.11, marking an increase of 4.93.
- For PBT / Share (Rs.), as of Mar 24, the value is 26.24. This value is within the healthy range. It has increased from 21.72 (Mar 23) to 26.24, marking an increase of 4.52.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 21.48. This value is within the healthy range. It has increased from 16.57 (Mar 23) to 21.48, marking an increase of 4.91.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 21.48. This value is within the healthy range. It has increased from 16.64 (Mar 23) to 21.48, marking an increase of 4.84.
- For PBDIT Margin (%), as of Mar 24, the value is 19.00. This value is within the healthy range. It has increased from 15.88 (Mar 23) to 19.00, marking an increase of 3.12.
- For PBIT Margin (%), as of Mar 24, the value is 16.76. This value is within the healthy range. It has increased from 13.65 (Mar 23) to 16.76, marking an increase of 3.11.
- For PBT Margin (%), as of Mar 24, the value is 15.65. This value is within the healthy range. It has increased from 12.79 (Mar 23) to 15.65, marking an increase of 2.86.
- For Net Profit Margin (%), as of Mar 24, the value is 12.81. This value exceeds the healthy maximum of 10. It has increased from 9.75 (Mar 23) to 12.81, marking an increase of 3.06.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 12.81. This value is within the healthy range. It has increased from 9.80 (Mar 23) to 12.81, marking an increase of 3.01.
- For Return on Networth / Equity (%), as of Mar 24, the value is 19.77. This value is within the healthy range. It has increased from 13.21 (Mar 23) to 19.77, marking an increase of 6.56.
- For Return on Capital Employeed (%), as of Mar 24, the value is 23.24. This value is within the healthy range. It has increased from 16.15 (Mar 23) to 23.24, marking an increase of 7.09.
- For Return On Assets (%), as of Mar 24, the value is 12.16. This value is within the healthy range. It has increased from 8.29 (Mar 23) to 12.16, marking an increase of 3.87.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.07, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.19. This value is within the healthy range. It has decreased from 0.22 (Mar 23) to 0.19, marking a decrease of 0.03.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.88. It has increased from 0.71 (Mar 23) to 0.88, marking an increase of 0.17.
- For Current Ratio (X), as of Mar 24, the value is 1.61. This value is within the healthy range. It has decreased from 1.80 (Mar 23) to 1.61, marking a decrease of 0.19.
- For Quick Ratio (X), as of Mar 24, the value is 1.01. This value is within the healthy range. It has decreased from 1.18 (Mar 23) to 1.01, marking a decrease of 0.17.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.56. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 23) to 0.56, marking an increase of 0.56.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 27.92. This value is within the healthy range. It has decreased from 60.09 (Mar 23) to 27.92, marking a decrease of 32.17.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 23.78. This value is within the healthy range. It has decreased from 48.96 (Mar 23) to 23.78, marking a decrease of 25.18.
- For Earning Retention Ratio (%), as of Mar 24, the value is 72.08. This value exceeds the healthy maximum of 70. It has increased from 39.91 (Mar 23) to 72.08, marking an increase of 32.17.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 76.22. This value exceeds the healthy maximum of 70. It has increased from 51.04 (Mar 23) to 76.22, marking an increase of 25.18.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 21.08. This value is within the healthy range. It has increased from 18.44 (Mar 23) to 21.08, marking an increase of 2.64.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 15.45. This value is within the healthy range. It has increased from 12.33 (Mar 23) to 15.45, marking an increase of 3.12.
- For Enterprise Value (Cr.), as of Mar 24, the value is 5,953.91. It has decreased from 7,242.13 (Mar 23) to 5,953.91, marking a decrease of 1,288.22.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.15. This value exceeds the healthy maximum of 3. It has decreased from 6.10 (Mar 23) to 5.15, marking a decrease of 0.95.
- For EV / EBITDA (X), as of Mar 24, the value is 27.11. This value exceeds the healthy maximum of 15. It has decreased from 38.40 (Mar 23) to 27.11, marking a decrease of 11.29.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 5.06. This value exceeds the healthy maximum of 3. It has decreased from 5.98 (Mar 23) to 5.06, marking a decrease of 0.92.
- For Retention Ratios (%), as of Mar 24, the value is 72.07. This value exceeds the healthy maximum of 70. It has increased from 39.90 (Mar 23) to 72.07, marking an increase of 32.17.
- For Price / BV (X), as of Mar 24, the value is 7.81. This value exceeds the healthy maximum of 3. It has decreased from 8.06 (Mar 23) to 7.81, marking a decrease of 0.25.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 5.06. This value exceeds the healthy maximum of 3. It has decreased from 5.98 (Mar 23) to 5.06, marking a decrease of 0.92.
- For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 23) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Symphony Ltd:
- Net Profit Margin: 12.81%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.24% (Industry Average ROCE: 16.63%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.77% (Industry Average ROE: 14.78%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 15.45
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.01
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34.8 (Industry average Stock P/E: 56.49)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.81%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Consumer Electronics | Symphony House, Third Floor, FP-12, Ahmedabad Gujarat 380059 | investors@symphonylimited.com http://www.symphonylimited.com |
Management | |
---|---|
Name | Position Held |
Mr. Achal Bakeri | Chairman & Managing Director |
Mr. Nrupesh Shah | Managing Director |
Mr. Amit Kumar | Executive Director & Group CEO |
Mr. Jonaki Bakeri | Non Executive Director |
Mr. Naishadh Parikh | Independent Director |
Mr. Ashish Deshpande | Independent Director |
Mrs. Reena Bhagwati | Independent Director |
Mr. Santosh Nema | Independent Director |
FAQ
What is the latest intrinsic value of Symphony Ltd?
The latest intrinsic value of Symphony Ltd as on 10 March 2025 is ₹537.19, which is 53.33% lower than the current market price of 1,151.00, indicating the stock is overvalued by 53.33%. The intrinsic value of Symphony Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹7,939 Cr. and recorded a high/low of ₹1,881/820 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹716 Cr and total liabilities of ₹1,463 Cr.
What is the Market Cap of Symphony Ltd?
The Market Cap of Symphony Ltd is 7,939 Cr..
What is the current Stock Price of Symphony Ltd as on 10 March 2025?
The current stock price of Symphony Ltd as on 10 March 2025 is ₹1,151.
What is the High / Low of Symphony Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Symphony Ltd stocks is ₹1,881/820.
What is the Stock P/E of Symphony Ltd?
The Stock P/E of Symphony Ltd is 34.8.
What is the Book Value of Symphony Ltd?
The Book Value of Symphony Ltd is 106.
What is the Dividend Yield of Symphony Ltd?
The Dividend Yield of Symphony Ltd is 1.13 %.
What is the ROCE of Symphony Ltd?
The ROCE of Symphony Ltd is 18.8 %.
What is the ROE of Symphony Ltd?
The ROE of Symphony Ltd is 18.0 %.
What is the Face Value of Symphony Ltd?
The Face Value of Symphony Ltd is 2.00.